Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study
- PMID: 20149389
- PMCID: PMC2854210
- DOI: 10.1016/j.jpeds.2009.11.061
Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study
Abstract
Objective: To identify predictors of antithrombotic treatment in neonates with cerebral sinovenous thrombosis (CSVT) in a large multinational study.
Study design: Neonates with CSVT from 10 countries were enrolled in the International Pediatric Stroke Study from 2003 through 2007. Term neonates with CSVT who presented with neurologic symptoms or signs of systemic illness and neuroimaging evidence of thrombus or flow interruption within cerebral venous system were included.
Results: Of 341 neonates enrolled, 84 had isolated CSVT. Neuroimaging findings, available in 67/84 neonates, included venous ischemic infarction in 5, hemorrhagic infarction or other intracranial hemorrhage in 13, both infarction and hemorrhage in 26, and no parenchymal lesions in 23. Treatment data, available in 81/84 neonates, included antithrombotic medications in 52% (n = 43), comprising heparin (n = 14), low molecular weight heparin (n = 34), warfarin (n = 1), and aspirin (n = 2). By univariate logistic regression analysis, deep venous system thrombosis (P = .05) and location in the United States (P = .001) predicted nontreatment. Presence of infarction, hemorrhage, dehydration, systemic illness, and age did not predict treatment or nontreatment. In multivariate analysis only geographic location remained significant.
Conclusions: In neonatal CSVT, regional antithrombotic treatment practices demonstrate considerable variability and uncertainty about indications for antithrombotic therapy. Additional studies are warranted.
Figures

Comment in
-
Neonatal cerebral venous thrombosis: le debut.J Pediatr. 2010 May;156(5):695-6. doi: 10.1016/j.jpeds.2010.01.004. Epub 2010 Mar 16. J Pediatr. 2010. PMID: 20236660 No abstract available.
Similar articles
-
Anticoagulants in pediatric cerebral sinovenous thrombosis: a safety and outcome study.Ann Neurol. 2010 May;67(5):590-9. doi: 10.1002/ana.21936. Ann Neurol. 2010. PMID: 20437556
-
Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome.Brain. 2005 Mar;128(Pt 3):477-89. doi: 10.1093/brain/awh412. Epub 2005 Feb 7. Brain. 2005. PMID: 15699061
-
Cerebral venous congestion as indication for thrombolytic treatment.Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):675-87. doi: 10.1007/s00270-007-9046-1. Cardiovasc Intervent Radiol. 2007. PMID: 17573553
-
Pediatric sinovenous thrombosis.J Pediatr Hematol Oncol. 2003 Apr;25(4):312-5. doi: 10.1097/00043426-200304000-00009. J Pediatr Hematol Oncol. 2003. PMID: 12679646 Review.
-
Research advances in neonatal cerebral sinovenous thrombosis.Zhongguo Dang Dai Er Ke Za Zhi. 2021 Aug 15;23(8):860-866. doi: 10.7499/j.issn.1008-8830.2105146. Zhongguo Dang Dai Er Ke Za Zhi. 2021. PMID: 34511178 Free PMC article. Review. Chinese, English.
Cited by
-
Subpial hemorrhages in neonates: imaging features, clinical factors and outcomes.Sci Rep. 2023 Feb 28;13(1):3408. doi: 10.1038/s41598-023-30332-5. Sci Rep. 2023. PMID: 36854783 Free PMC article.
-
Baby STEPS: a giant leap for cell therapy in neonatal brain injury.Pediatr Res. 2011 Jul;70(1):3-9. doi: 10.1203/PDR.0b013e31821d0d00. Pediatr Res. 2011. PMID: 21659957 Free PMC article. Review.
-
Contralateral Massive Neonatal Arterial Ischemic Stroke Secondary to Carotid Artery Dissection: A Case Report.Cureus. 2023 Nov 7;15(11):e48452. doi: 10.7759/cureus.48452. eCollection 2023 Nov. Cureus. 2023. PMID: 38073993 Free PMC article.
-
Sigmoid Sinus Thrombosis As Complication of Otitis Media in a 3-Year-Old Boy: Case Report and Review of the Literature.Cureus. 2022 Feb 15;14(2):e22262. doi: 10.7759/cureus.22262. eCollection 2022 Feb. Cureus. 2022. PMID: 35340493 Free PMC article.
-
Early detection of cerebral sinus venous thrombosis in an extremely low birth weight infant using cranial ultrasound-case report and literature review.Childs Nerv Syst. 2024 Nov 27;41(1):7. doi: 10.1007/s00381-024-06659-3. Childs Nerv Syst. 2024. PMID: 39604669 Free PMC article. Review.
References
-
- Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):645S–87S. - PubMed
-
- Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P, et al. Antithrombotic therapy in neonates and children: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):887S–968S. - PubMed
-
- Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, et al. Management of stroke in infants and children: A scientific statement from a special writing group of the american heart association stroke council and the council on cardiovascular disease in the young. Stroke. 2008;39:2644–91. - PubMed
-
- deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417–23. - PubMed
-
- Kenet G, Kirkham F, Niederstadt T, Heinecke A, Saunders D, Stoll M, Brenner B, Bidlingmaier C, Heller C, Knöfler R, Schobess R, Zieger B, Sébire G, Nowak-Göttl U, European Thromboses Study Group Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol. 2007;6:595–603. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources